You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》匯豐研究降平安好醫生(01833.HK)目標價至14元 評級「持有」
阿思達克 03-22 15:44
匯豐研究發表報告指,雖然已經預計平安好醫生(01833.HK)去年下半年錄得負增長,但最終的收入仍較預測低16%。ToB用戶增長符合預期,但每使用者平均收入(ARPU)略遜預期。整體而言,該行將集團2024及25年的收入預測削減12%和14%,但繼續預期收入增長將從2024年上半年開始轉為正數,又將目標價由18.5元下調至14元,維持「持有」評級。 該行提到,集團去年下半年收入為24.5億元人民幣,按年下跌27%,惟與上半年比較則上升10%。收入遜於預期,因ToF和ToB的戰略業務較預期弱。毛利率為32.4%,符合預期;經調整淨虧損收窄至6,600萬元人民幣。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account